Methodology Report
Effective and Steady Differentiation of a Clonal Derivative of P19CL6 Embryonal Carcinoma Cell Line into Beating Cardiomyocytes
Table 1
The conditions of differentiation protocol and differentiation efficiency for P19CL6 and P19CL6-A1 cells.
| Cell line | P19CL6 | PI9CL6-Al | P19CL6 |
| Differentiation protocol | Basal protocol | Developed protocol | Ohtsu et al. [12] | Medium | -MEM | DMEM | -MEM | FBS: concentration | 6.5% | 7.5% | 10% | 5-Aza: concentration and incubation time | 10 M | 10 M | 10 M | 24 hours | 72 hours | 24 hours | DMSO: concentration and incubation time | 1% | 1% | 1% | days | days | 16 days | Coating | Collagen | Collagen | — | (Type I-A) | (Type I-A) | -actin-positive cell area to total field* | 7.0% | 38.3% | — | Relative intensity of -MHC mRNA expression** | 1.0 | 1.77 | — |
|
|
, Differentiation efficiency measured by immunofluorescence microscopy () and RT-PCR () on day 16.
|